FAMDF / Futura Medical targets profitability as it sees early commercial traction for ED gel

Futura Medical's Eroxon erectile dysfunction treatment won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023 follo more_horizontal

Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in innovative sexual health products, has announced OTC Marketing Autho more_horizontal

The roll-out of Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s breakthrough erectile dysfunction gel continues apace with sales starting in the company's more_horizontal

Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in sexual health products, has witnessed a 3% increase in its share pri more_horizontal

Futura Medical PLC (AIM:FUM, OTC:FAMDF), the drug developer specialising in sexual health products, has secured a significant win with the European Pa more_horizontal

In an exclusive with Proactive, James Barder, CEO of Futura Medical PLC (AIM:FUM, OTC:FAMDF), discusses the company's remarkable first half of the yea more_horizontal

The past year has seen the pieces of the puzzle fall neatly into place for UK-based Futura Medical PLC (AIM:FUM, OTC:FAMDF), according to boutique inv more_horizontal

Futura Medical PLC said it expects to be in a break-even position next year as the commercial traction grows around its erectile dysfunction gel Ero more_horizontal